{
  "report_rows": [
    {
      "kpi": "Core FFO per share",
      "prediction": "BEAT",
      "answer": "pred ~$4.31 vs. cons $4.25",
      "confidence": "MEDIUM"
    },
    {
      "kpi": "Same-store revenue growth",
      "prediction": "BEAT",
      "answer": "pred ~-0.7% vs. cons -0.9%",
      "confidence": "MEDIUM"
    },
    {
      "kpi": "Same-store NOI growth",
      "prediction": "MISS",
      "answer": "pred ~-1.7% vs. cons -1.5%",
      "confidence": "MEDIUM"
    }
  ],
  "guide_rows": [
    {
      "kpi": "Core FFO per share guidance",
      "prediction": "LOWER",
      "answer": "guide ~$16.90 vs. cons $16.94 (FY2026)",
      "confidence": "MEDIUM"
    },
    {
      "kpi": "Same-store revenue growth guidance",
      "prediction": "BETTER",
      "answer": "guide ~-0.9% vs. cons -1.0% (FY2026)",
      "confidence": "MEDIUM"
    },
    {
      "kpi": "NSA Core FFO per-share accretion commentary",
      "prediction": "LOWER",
      "answer": "guide ~$0.18 vs. cons $0.20 (FY2027)",
      "confidence": "LOW"
    }
  ],
  "day1_residual_pct": -2.2,
  "day1_confidence": "MEDIUM",
  "day5_residual_pct": -3.4,
  "day5_path": "FOLLOW-THROUGH",
  "day5_rationale": "A modest Q2 Core FFO beat is outweighed by guide ~$16.90 vs. cons $16.94 for FY2026 and NSA accretion of ~$0.18 vs. cons $0.20 for FY2027, prompting out-period estimate cuts after the initial reaction.",
  "day5_confidence": "MEDIUM"
}